Aurobindo Pharma, Intas in race to buy Mallinckrodt's US generic business
Aurobindo Pharma and Intas are in the race to buy UK-based Mallinckrodt's generic drugs business in the US valued at USD 2 billion, this will be the biggest ever overseas acquisition for any Indian drug maker.
https://www.google.com.au/amp/www.moneycontrol.com/news/business/aurobindo-pharma-intas-in-race-to-buy-mallinckrodts-us-generic-business-2354219.html/amp
This is not fluff, page-5
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.015(0.99%) |
Mkt cap ! $1.712B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $4.588M | 3.048M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 25808 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 15759 | 6 |
View Market Depth
| Last trade - 15.12pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |